ChristinaIsabellaHeroldMD

Oncology • Boston, MA

Breast Cancer, Hematologic Oncology

Instructor in Medicine, Dana-Farber Cancer Institute, Harvard Medical School

Join to view full profile

Dr. Herold is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Herold's full profile

Already have an account?

Office
450 Brookline Avenue
Suite YC-1250
Boston, MA 02215
Phone+1 617-632-3800

Fax+1 617-632-2337
Is this information wrong?

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 2006 - 2009
University of Pennsylvania Health SystemResidency, Internal Medicine, 2003 - 2006
Harvard Medical SchoolClass of 2002

Certifications & Licensure

MA State Medical License 2009 - 2020
NC State Medical License 2006 - 2009
PA State Medical License 2002 - 2006

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) Start of enrollment: 2013 May 01
Active, not recruiting
Phase 2
GSK1120212+GSK2141795 for Cervical Cancer Start of enrollment: 2013 Oct 01
Terminated
Phase 2

Publications & Presentations

PubMed

134 citations
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial
Joyce F. Liu, Christina I. Herold, Kathryn P. Gray, Richard T. Penson, Neil S. Horowitz, Panagiotis A. Konstantinopoulos, Cesar M. Castro, Sarah J. Hill, Jennifer Curt...> ;JAMA Oncology. 2019 Oct 10
117 citations
Translational breast cancer research consortium (TBCRC) 022: A phase II trial of neratinib for patients with human epidermal growth factor receptor 2-positive breast c...
Rachel A. Freedman, Rebecca Gelman, Jeffrey S. Wefel, Michelle E. Melisko, Kenneth R. Hess, Roisin M. Connolly, Catherine Van Poznak, Polly A. Niravath, Shannon Puhall...> ;Journal of Clinical Oncology. 2016 Sep 19
22 citations
Early-Stage Breast Cancer in the Octogenarian: Tumor Characteristics, Treatment Choices, and Clinical Outcomes.
Anita Mamtani, Julie J. Gonzalez, Dayna Neo, Priscilla J. Slanetz, Mary Jane Houlihan, Christina I. Herold, Abram Recht, Michele R. Hacker, Ranjna Sharma> ;Annals of Surgical Oncology. 2016 Jun 30
25 citations
Cervical cancer control in Latin America: A call to action
Brittany L. Bychkovsky, Mayra Ferreyra, Kathrin Strasser-Weippl, Christina I. Herold, Gilberto Lopes, Don S. Dizon, Kathleen M. Schmeler, Marcela G. del Carmen, Thomas...> ;Cancer. 2016 Feb 15
317 citations
Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next‐generation sequencing with a 25‐gene panel
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh R. Kaldate, Satish Bhatnagar, Karla R. Bowles, Kirsten Timms, Judy Garber, Christina I. Herold, Leif W. Ellisen, Jill...> ;Cancer. 2015 Jan 1
33 citations
New targets for triple-negative breast cancer.
Christina I. Herold, Carey K. Anders> ;Oncology. 2013 Sep 1
10 citations
Second primary ipsilateral breast cancer with contralateral axillary involvement: a case report and literature review.
Christina I. Herold, Elizabeth M. Gaughan, Carolyn C. Lamb, Nadine Tung> ;Clinical Breast Cancer. 2011 Dec 1
59 citations
Phase II Trial of Dasatinib in Patients with Metastatic Breast Cancer Using Real-Time Pharmacodynamic Tissue Biomarkers of Src Inhibition to Escalate Dosing
Christina I. Herold, Vijaya Chadaram, Bercedis L. Peterson, P. Kelly Marcom, Judith O. Hopkins, Gretchen Kimmick, Justin Favaro, Erika Hamilton, Renee Welch, Sarah S. ...> ;Clinical Cancer Research. 2011 Sep 15
478 citations
Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers.
Andrew J. Armstrong, Matthew S. Marengo, Sebastian Oltean, Gabor Kemeny, Rhonda L. Bitting, James D. Turnbull, Christina I. Herold, Paul K. Marcom, Daniel J. George, M...> ;Molecular Cancer Research. 2011 Aug 1
2 citations
Lenalidomide-Associated ITP
Christina I. Herold, Cristina Gasparetto, Gowthami M. Arepally> ;Case Reports in Hematology. 2011 Jul 17
2 citations
Reliable data on 5- and 10-year survival provide accurate estimates of 15-year survival in estrogen receptor-positive early-stage breast cancer
Christina I. Herold, Benjamin Djulbegovic, Iztok Hozo, Gary H. Lyman> ;Breast Cancer Research and Treatment. 2010 Jun 1
Comparative genomic and protein signatures and intratumoral treatment responses in patients with metastatic breast cancer (MBC) treated with paclitaxel (PTX) and 2-met...
Herold CI, Yang I, Chi J, Sidor C, Parrillo L, Liotcheva V, Welch RA, Arnott J, Dewhirst MW, Blackwell KL> ;J. Clin. Oncol.. 2009-05-20
5 citations
Primary systemic therapy in breast cancer: past lessons and new approaches.
Christina I. Herold, P. Kelly Marcom> ;Cancer Investigation. 2008 Dec 1
21 citations
Aromatase inhibitors for breast cancer: proven efficacy across the spectrum of disease.
Christinal I. Herold, Kimberly L. Blackwell> ;Clinical Breast Cancer. 2008 Feb 1
5 citations
The impact of adjuvant endocrine therapy on reducing the risk of distant metastases in hormone-responsive breast cancer.
Christina I. Herold, Kimberly L. Blackwell> ;Breast. 2008 Jan 1
Factors that influence genetic testing outcomes in high-risk breast/ovarian families.
Herold CI, Goldfeder KL, Tigges J, Stopfer JE, Weber BL, Domchek SM> ;J. Clin. Oncol.. 2005-06-01
Join now to see all

Press Mentions

Bird Brains Are Surprisingly ComplexSeptember 28th, 2020

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Dana-Farber Cancer InstituteBoston, Massachusetts